Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal steroid dose with leukotriene inhibitor in snoring children with adenotonsillar hypertrophy
TCTR20251212007Phase 3Not yet recruiting
- Sponsor
- Naresuan University Hospital
- Start
- Jan 2026
- Countries
- 1
01
Overview
Phase 3 trial in Adenotonsillar hypertrophy (ATH) and sleep disordered breathing (SDB), sponsored by Naresuan University Hospital. Planned start Jan 2026; status: not yet recruiting.
02
Conditions
Adenotonsillar hypertrophy (ATH)sleep disordered breathing (SDB)
Beyond the preview
Go deeper on TCTR20251212007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251212007.